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Background: The purpose of this study was to identify the ultrasonographic findings that
reflected disease severity in patients with autosomal dominant polycystic kidney disease
(ADPKD).
Materials and Methods: In 72 patients with ADPKD, resistive indices (RIs) and the sever-
ity of ultrasonographic morphologic abnormalities, such as renal severity index (RSI),
modified RSI and the sum of bilateral renal size, were measured and correlated with clin-
ical and laboratory findings including the presence of hypertension and serum creatinine
concentration. RSI was calculated as the sum of three components in both kidneys and
included the number of cysts, the size of the largest cyst, and the percentage of normal
renal parenchyma. Modified RSI was the sum of the RSI and the score according to the
size of both kidneys.
Results: Mean RI in all patients was 0.62 ± 0.09 (mean ± 1 standard deviation). RIs in
hypertensive ADPKD patients (0.63 ± 0.11) were higher compared with normotensive
patients (0.58 ± 0.05) (p < 0.05). Serum creatinine concentration representing renal func-
tion correlated significantly with RIs (r = 0.630, p < 0.01) and with RSIs (r = 0.344, p < 0.01).
The correlation between renal size and serum creatinine concentration or RIs was rela-
tively weak (r = 0.232, r = 0.298, respectively).
Conclusion: RI and RSI were useful parameters in the quantitative evaluation of disease
severity and may reflect renal functional status in patients with ADPKD.
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Introduction
Autosomal dominant polycystic kidney disease
(ADPKD) is an important cause of end-stage renal
disease, accounting for approximately 6–9% of
patients with end-stage renal disease in North
America and Europe [1]. It is a hereditary disorder
characterized by remarkable cysts arising anywhere
in the collecting duct or nephron and by common
extrarenal manifestations such as hepatic cysts,
pancreatic cysts, and cerebral aneurysms.
ADPKD can be diagnosed before symptoms de-
velop by ultrasonographic imaging of the kidneys
for renal cysts. Conventional ultrasonography (US)
has been proved to be an accurate and reliable
technique to accurately determine kidney size as
well as the presence, number and extent of renal
cysts. Renal complications arise largely as a con-
sequence of the structural deformities, with end-
stage renal failure being the most common serious
sequela of the disease. However, patients with
ADPKD exhibit wide interindividual variation in the
age at onset of renal dysfunction or the progression
rate to end-stage renal failure due to genetic and
multiple nongenetic factors [2]. The rate of renal
deterioration seems to correlate with the rate of cyst
growth, supposedly because the enlarging cysts
cause pressure atrophy, which can lead to local
ischemia and the increased generation of renin–
angiotensin accompanied by hypertension. Quan-
tification of the morphologic US abnormalities in
ADPKD patients can be determined by means of
the anatomical renal severity index (RSI) as sug-
gested by Gabow et al [3]. With this method, the
number of cysts are counted, the largest cyst is
measured, and the percentage of normal renal
parenchyma is estimated qualitatively by compar-
ing the area of unaffected parenchyma to the tissue
replaced by cyst. In addition, Doppler US may be
useful in the evaluation of patients with ADPKD,
because it can provide additional information
regarding the hemodynamic status of the kidney.
The purpose of our study was to identify
whether ultrasonographic findings could reflect dis-
ease severity in patients with ADPKD by measuring
resistive index (RI), RSI, modified RSI and renal
size, and to correlate these measured parameters
with renal function and the presence of arterial
hypertension.
Materials and Methods
This study was a retrospective analysis of 72 con-
secutive patients who were diagnosed with ADPKD.
All patients included in this series were imaged
with grayscale, color Doppler and pulsed Doppler
sonography. Thirty-three male patients and 39 fe-
male patients were included. The age of these
patients ranged from 16 to 75 years (mean, 47
years). Our institutional review board did not require
approval or informed consent for this retrospective
evaluation of the patients’ records and images.
The diagnosis of ADPKD was made on the basis
of ultrasonographic criteria and family history. Sub-
jects were considered to have ADPKD if there were
bilateral renal cysts totaling five or more on ultra-
sonography. For family members of the patients
with ADPKD, we used the criteria proposed by
Ravine et al [4], which included the presence of at
least two renal cysts (unilateral or bilateral) in an
individual younger than 30 years, the presence of
at least two cysts in each kidney in patients aged
30–59 years, and at least four cysts in each kidney 
in patients aged 60 years or older. Some elderly
patients with no evidence of kidney disease in their
family history or past medical records were ex-
cluded from the study, as it was impossible to dis-
tinguish their findings from multiple bilateral
cortical cysts.
In each patient, clinical and laboratory data, in-
cluding serum creatinine concentration (in milli-
grams per deciliter) and the presence or absence
of hypertension, were determined. Hypertension
was defined as a diastolic pressure greater than
90 mmHg or a systolic pressure greater than
140 mmHg in the sitting position, or a known his-
tory of antihypertensive therapy. In accordance with
this definition, 54 of the 72 patients were found 
to be hypertensive. We used serum creatinine 
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concentrations as an indicator of renal functional
status, which were measured in all patients while
on an ad libitum diet. The time interval between
blood sampling for laboratory examination and US
examination was less than 3 days. All US examina-
tions were performed without knowledge of the
laboratory findings in all patients.
Sonograms of each kidney were obtained using
a 2–4MHz curved-array probe (HDI 3000; Advanced
Technology Laboratories, Bothell, WA, USA), which
included longitudinal scans of each kidney to allow
measurement of approximate renal size. In addi-
tion, quantification of the morphologic US ab-
normalities in ADPKD patients was performed by
means of the anatomical renal severity index (RSI)
as suggested by Gabow et al [3] (Table 1). For the
measurement of RSI, the number of cysts was
determined, the largest cyst was measured, and
the percentage of normal renal parenchyma was
estimated by qualitatively comparing the area of
unaffected parenchyma to the tissue replaced by
the cyst. The RSI was then calculated as the sum of
the three scores in both kidneys. A score of 0 was
equivalent to the absence of cysts on US, whereas
a score of 18 represented the most severe form of
ADPKD. Considering the effect of renal enlarge-
ment, we used modified RSI, that is the sum of RSI
and the score according to the size of both kidneys
(Table 1), which ranged from 0 to 24.
In addition to detailed grayscale ultrasonogra-
phy, Doppler examinations were performed. For the
Doppler study, the wall filter was set at minimum
and the sample volume was set at 2–5 mm. The
Doppler signal was obtained in the area of the
arcuate arteries at the corticomedullary junction
and/or interlobar arteries along the border of the
medullary pyramids. In the presence of severe pa-
renchymal distortion or obliterated renal sinus 
due to extensive cyst development, we obtained
Doppler spectra from the furthest peripheral site. 
A minimum of three consecutive, similar-appearing
waveforms were obtained to ensure that move-
ment of the Doppler sample volume or change in
the Doppler interrogation angle had not occurred
during waveform acquisition. From the Doppler
spectra, the RI, defined as (peak systolic frequency
shift-end diastolic frequency shift)/peak systolic fre-
quency shift, was calculated. The RI was obtained
from three different areas on each kidney and the
average value was taken.
Sonographic indices (RI, RSI, modified RSI, the
sum of bilateral renal size) were compared in nor-
motensive and hypertensive ADPKD patients as
well as in patients with preserved and abnormal
renal function. The correlations between age, renal
RI, serum creatinine level, RSI, modified RSI and
the sum of bilateral renal size were evaluated.
Statistical comparisons between the various
groups were performed using independent samples
t tests. The Pearson’s method was applied to all
ADPKD patients to estimate the presence of linear
correlations between age, renal RI, serum creati-
nine level, RSI, modified RSI and the sum of bilat-
eral renal size. Covariation was expressed by the
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Table 1. Renal severity index (RSI)* and modified RSI† in autosomal dominant polycystic kidney disease patients:
scoring of ultrasonographic findings
Score No. of cysts Size of largest cyst (cm) Proportion of noncystic parenchyma Renal size (cm)
0 0 0 100% (no cysts) < 13
1 1–5 < 2 76–99% (scattered cysts) 13–16
2 6–15 2–5 25–75% (approximately equivalent 16–18
cystic and noncystic volumes)
3 > 15 > 5 < 25% (almost entirely cystic) > 18
*RSI is the sum of the scores of three component of the bilateral kidneys (number of cysts, size of the largest cyst, proportion of noncystic parenchyma);
†modified RSI is the sum of RSI and the scores of the renal size component (e.g., RSI ranges from 0 to 18 and modified RSI ranges from 0 to 24; a score
of 0 would be equivalent to an absence of cysts on ultrasonography). 
correlation coefficient. A two-sided 5% level of sig-
nificance was used.
Results
For all 72 patients, the mean RSI was 13.5 ± 3.2,
the mean modified RSI was 14.7 ± 3.8, the mean
renal size (sum of both kidneys) was 30.2 ± 4.8 cm,
the mean renal RI was 0.62 ± 0.10, and the mean
serum creatinine level was 1.8 ± 1.8 mg/dL. Fifty-
four ADPKD patients (25 females, 29 males; mean
age, 49.1 years) were hypertensive, and 18 ADPKD
patients (14 females, 4 males; mean age, 40 years)
were normotensive.
Mean RIs were higher in hypertensive ADPKD
patients than in normotensive patients (0.63 ± 0.11
vs. 0.58 ± 0.05; p = 0.039; Table 2). RI elevation
(> 0.7) was noted in 20% (11/54) of patients with
hypertension, and in 0% (0/18) of normotensive
patients. Mean RSI, modified RSI, renal size, and
serum creatinine level in hypertensive ADPKD
patients were 14.3 ± 2.9, 15.6 ± 3.4, 31.4 ± 4.3 cm,
and 1.9 ± 1.8 mg/dL, respectively. Mean RSI, mod-
ified RSI, renal size, and serum creatinine level in
normotensive ADPKD patients were 11.3 ± 3.0,
11.9 ± 3.5, 26.6 ± 4.4 cm, and 1.3 ± 1.7 mg/dL, re-
spectively. There were statistically significant differ-
ences in RSI, modified RSI, and renal size between
the two patient groups (p<0.01). However, the level
of serum creatinine was not significantly different
between the two groups (p = 0.159).
When we used a serum creatinine level of
1.4 mg/dL as a cut-off value for predicting renal
dysfunction, there were 52 patients with normal re-
nal function and 20 patients with abnormal renal
function (Table 3). In the 52 patients with normal
renal function, the mean serum creatinine level,
mean age, mean RSI, modified RSI, renal size, and
renal RI were 1.0 ± 0.2 mg/dL, 43 years, 12.6 ± 3.1,
13.6 ± 3.7, 29.2 ± 4.5 cm, and 0.59 ± 0.05, respec-
tively. Among these patients, 35 were hypertensive
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Table 2. Results according to the presence of hypertension*
All ADPKD Hypertensive Normotensive 
p†
(n = 72) ADPKD (n = 54) ADPKD (n = 18)
SCr (mg/dL) 1.8 (1.8) 1.9 (1.8) 1.3 (1.7) 0.159
RI 0.62 (0.10) 0.63 (0.11) 0.58 (0.05) 0.039
RSI 13.5 (3.2) 14.3 (2.9) 11.3 (3.0) < 0.01
Modified RSI 14.7 (3.8) 15.6 (3.4) 11.9 (3.5) < 0.01
Renal size (cm) 30.2 (4.8) 31.4 (4.3) 26.6 (4.4) < 0.01
*Data are presented as mean (standard deviation); †statistical difference between hypertensive and normotensive ADPKD. ADPKD = autosomal
dominant polycystic kidney disease; SCr = serum creatinine concentration; RI = resistive index; RSI = renal severity index.
Table 3. Results according to the level of serum creatinine at a cut-off value of 1.4*
ADPKD with normal renal function, ADPKD with abnormal renal function, 
p†
i.e. SCr < 1.4 mg/dL (n = 52) i.e. SCr > 1.4 mg/dL (n = 20)
SCr (mg/dL) 1.0 (0.2) 3.8 (2.4) < 0.01
RI 0.59 (0.05) 0.71 (0.13) < 0.01
RSI 12.6 (3.1) 15.9 (1.8) < 0.01
Modified RSI 13.6 (3.7) 17.5 (2.4) < 0.01
Renal size (cm) 29.2 (4.5) 32.8 (4.6) < 0.01
*Data are presented as mean (standard deviation); †statistical difference between the two groups. ADPKD = autosomal dominant polycystic kidney
disease; SCr = serum creatinine concentration; RI = resistive index; RSI = renal severity index.
(67%) and 17 were normotensive (33%). In the 
20 patients with abnormal renal function, the mean
serum creatinine level, mean age, mean RSI, mod-
ified RSI, renal size, and renal RI were 3.8 ± 2.4 mg/
dL, 56.2 years, 15.9 ± 1.8, 17.5 ± 2.4, 32.8 ± 4.6 cm,
and 0.71 ± 0.13, respectively. Among these patients,
19 were hypertensive (95%) and only one was
normotensive (5%). Statistically significant differ-
ences in age, RSI, modified RSI, renal size, renal RI,
and the incidence of hypertension between the
two groups were observed (p < 0.01).
When we used a renal RI of 0.7 as a cut-off value,
RI elevation was noted in 11 of the 72 patients
(15%), all of whom were hypertensive. In these 11
patients with elevated renal RI, the mean renal RI,
mean serum creatinine level, mean RSI, modified
RSI, and renal size were 0.81 ± 0.09 (range, 0.71–
1.0), 4.0 ± 2.9 mg/dL, 15.5 ± 2.8, 17.3 ± 3.6, and
33.0 ± 5.1 cm, respectively. In the remaining 61
patients (85%) with normal renal RI, the mean
renal RI, mean serum creatinine level, mean RSI,
modified RSI, and renal size were 0.59 ± 0.05
(range, 0.50–0.69), 1.37 ± 1.16 mg/dL, 13.2 ± 3.1,
14.2 ± 3.6, and 29.7 ± 4.5 cm, respectively. Among
these patients, 43 were hypertensive (70%) and 
18 were normotensive (30%).
The correlations between age, renal RI, serum
creatinine level, RSI, modified RSI and renal size 
are shown in Table 4 and Figs. 1, 2 and 3. All were
correlated significantly at the 0.05 level (two-
tailed). When 99% confidence limits were used,
renal size was not significantly correlated with 
age, renal RI or serum creatinine level (0.01 < p <
0.05). Renal RI correlated better with renal func-
tion as expressed by serum creatinine level than
the morphologic indices (mean RSI, modified RSI,
renal size). RSI and modified RSI showed similar
correlations with age, renal RI and serum creatinine
level.
Discussion
ADPKD is a very common hereditary disorder, the
manifestations of which are not restricted to the
kidney. The renal manifestations of ADPKD include
structural, functional and endocrine abnormalities
as well as renal complications. The main structural
change in the affected kidneys of patients with
ADPKD is the formation of cysts. Early in the dis-
ease, less than 5% of nephrons are cystic [5]. It is
not known whether more nephrons are recruited
into the cystic process over time or whether existing
cysts simply enlarge. Whichever process is involved,
it culminates in enlarged kidneys, which appear to
be replaced by cysts on gross examination.
Although most cases are identified when pa-
tients are between 30 and 50 years of age, the con-
dition has been recognized in newborns. ADPKD
can be diagnosed before symptoms develop by ul-
trasonographic imaging of the kidneys for renal
cysts. Because these cysts are usually undetectable
in children but become more numerous and larger
with age, the interpretation of negative findings is
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69J Med Ultrasound 2008 • Vol 16 • No 1
Table 4. Correlations between age, resistive index (RI), serum creatinine concentration (SCr), renal severity index
(RSI), modified RSI, and renal size
Age RI SCr
r p r p r p
Age – – 0.435 0.000 0.432 0.000
RI 0.435 0.000 – – 0.630 0.000
SCr 0.432 0.000 0.630 0.000 – –
RSI 0.378 0.001 0.350 0.003 0.344 0.003
Modified RSI 0.345 0.003 0.358 0.002 0.334 0.004
Renal size 0.264 0.025 0.298 0.011 0.232 0.050
age-dependent [6]. According to Ravine et al [4],
the ultrasonographic diagnostic criteria used for
screening subjects at risk of ADPKD are less strin-
gent in younger subjects than in older family
members in whom simple renal cysts are more fre-
quent. Because ADPKD is a progressive disease, it
is natural that statistically significant correlations
were observed between the age of the patient,
morphologic indices and renal functional status,
such as serum creatinine concentration, in our study
(p < 0.01). Thus, additional and larger cyst forma-
tion and progressive renal deterioration develop
with age.
Progressive renal failure is the most common
complication of ADPKD. Patients with ADPKD gen-
erally maintain normal renal function for a long
time, usually up to the fifth decade of life [1,7,8].
However, once renal failure starts, the progression
to end-stage renal failure generally takes less than
10 years [9], and approximately 60% of affected
individuals develop end-stage renal failure by the
sixth decade [1,7–10]. Patients with ADPKD ex-
hibit marked non-uniformity in the development
of renal dysfunction and in its rate of progression
to end-stage renal failure. The age at onset of 
renal dysfunction and the rate of decline in renal
function exhibit wide interindividual variation, sug-
gesting that factors other than the gene defect
may contribute to the progression of renal disease,
which probably depends on the interplay between
genetic and nongenetic factors. Identification of
these nongenetic factors might allow specific in-
tervention to remove or modify their impact and
thus favorably modulate the course of renal disease
in ADPKD. Among the nongenetic factors that
may influence disease progression, many studies
suggest that an elevated blood pressure or a family
history of primary hypertension is a determinant of
renal prognosis in ADPKD [11,12]. Hypertension in
ADPKD may accelerate the rate of progression of
renal insufficiency. However, the effectiveness of
blood pressure control in the progression of this
disease is debatable [13,14].
The renal complications of ADPKD arise largely
as a consequence of the structural deformities,
which are characterized by remarkable cyst devel-
opment within the kidney. This cystic deformation
C.K. Sung, S.H. Kim, C. Ahn
70 J Med Ultrasound 2008 • Vol 16 • No 1
Age (yr)
0 10
12
10
8
Se
ru
m
 c
re
at
in
in
e 
(m
g/
dL
)
6
4
2
0
−2
20 30 40 50 60 70 80
y = 0.066x – 1.3194
Fig. 1. Scatter diagram with sample regression line showing a
statistically significant correlation between serum creatinine
concentration and age (r = 0.432, p < 0.01).
Fig. 3. Scatter diagram with sample regression line showing a
statistically significant correlation between resistive index and
renal severity index (r = 0.350, p < 0.01).
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Fig. 2. Scatter diagram with sample regression line showing a
statistically significant correlation between resistive index and
serum creatinine concentration (r = 0.630; p < 0.01).
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is accompanied by hypertension in approximately
60% of individuals prior to the onset of azotemia
[15]. In fact, ADPKD individuals with hypertension
manifest more severe cystic involvement as assessed
by larger kidneys and, thus, additional and larger
cysts than do normotensive ADPKD individuals
[16]. This observation was expressed in our study
by morphologic indices such as RSI, modified RSI
and renal size. There were statistically significant
differences in those indices between hypertensive
and normotensive ADPKD patients. Thus, although
the pathogenesis of hypertension associated with
ADPKD has not been clearly established, it is reason-
able to suggest a relationship between structural
deformation and hypertension in the course of
ADPKD. Specifically, ADPKD has been shown to be
associated with activation of the renin–angiotensin–
aldosterone system [12,14,17,18], presumably by
stretching and attenuation of intrarenal vessels
around the cysts, causing areas of distal ischemia.
US has been commonly used as the initial
imaging procedure in the evaluation of patients
with renal diseases. Conventional grayscale US has
been proved to accurately determine renal size as
well as the presence, number and extent of renal
cysts. Because renal complications of ADPKD arise
largely as a consequence of the structural deformi-
ties, it is most important to evaluate the degree of
structural deformation of the kidneys by the cysts.
This evaluation can be accomplished using the
morphologic indices. There were significant corre-
lations between RSI, modified RSI, renal size and
serum creatinine concentration. In addition, there
were statistically significant differences in the RSI,
modified RSI, and renal size between hypertensive
and normotensive patients at the 95% confidence
level. However, there was no additional gain of
modified RSI over RSI for the prediction of renal
dysfunction. Renal size showed the least significance
in its correlation to serum creatinine concentration
and can be difficult to measure accurately, espe-
cially in the case of markedly enlarged kidneys.
Although grayscale US can provide detailed ana-
tomical information, it does not provide physio-
logic information. Doppler US has the potential to
provide physiologic information regarding the he-
modynamic status of the kidney. Color and power
Doppler US can easily demonstrate a general
decrease or increase in renal parenchymal blood
flow. However, hemodynamic changes in renal
blood flow should be assessed by Doppler spectral
analysis. Changes in intrarenal arterial Doppler
spectra have been shown to occur with various
renal diseases. In spite of the controversies, there is
substantial evidence to suggest that Doppler US
may aid in the differential diagnosis and treatment
of patients with various renal diseases [19–21]. The
RI is the most commonly used Doppler parameter
to determine the status of renal hemodynamics.
The RI has been reported to be related to imped-
ance (a combination of resistance and compliance),
not resistance alone, which alters the Doppler
waveform and the RI [22].
The stretching of intrarenal vessels around the
cysts in ADPKD causes intrarenal ischemia with
subsequent activation of the renin–angiotensin–
aldosterone system and elevation of renal vascular
resistance, which can be measured by Doppler US.
Our results showed statistically significant differ-
ences in renal RI between hypertensive and nor-
motensive patients at the 95% confidence level.
Although RI reflects renal vascular resistance, it also
correlated well with serum creatinine concentra-
tion (r = 0.630, p < 0.01). The correlation between
the elevated RI and renal dysfunction is probably
based on other parameters, which still need to 
be elucidated. Although measuring RI alone can-
not alter patient outcome, a strong correlation
between RI and the presence of hypertension in
ADPKD patients was observed in our study. It is
likely that Doppler RI could be used as an addi-
tional parameter in the assessment of the severity
of parenchymal involvement, the evolution of the
disease, and in the follow-up of patients during
medical therapy.
Our findings showed that the degree of renal
cystic involvement, which was measured by mor-
phologic indices, correlated with the elevation of
renal RI or renal function as expressed by the
serum creatinine level in ADPKD patients. Doppler
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RI correlated better with renal function than mor-
phologic indices (mean RSI, modified RSI, renal size).
Although renal size was correlated significantly with
renal function at the 95% confidence limit, the
correlation was lower than RSI or modified RSI. We
expected that modified RSI might increase the reli-
ability of morphologic indices in the evaluation of
ADPKD, because it adds the information about renal
size to RSI. However, there was no additional gain
of modified RSI over RSI, which means that RSI
itself contains the information regarding renal size.
One limitation of the present study is that it was
not designed in a longitudinal fashion. Evaluation
was carried out only once in each patient, some
were initial studies and others were follow-up
studies. A Doppler US follow-up of ADPKD patients
with serial examinations may offer a noninvasive
means of evaluating the progression of renal dys-
function and the response to treatment. In addition,
although creatinine clearance rate was available in
some patients, we used serum creatinine concentra-
tion as a parameter of renal function. Although the
level of serum creatinine is not the best laboratory
examination for the representation of renal func-
tional status, it is the most commonly used indicator
for evaluation of renal function in clinical practice.
ADPKD is a common hereditary disorder whose
manifestations are not restricted to the kidney. Ad-
vances in knowledge of this disorder allow im-
proved patient care, including the potential for
increased preservation of renal function and, per-
haps ultimately, the reversal of the cystic process.
Doppler US in conjunction with morphologic
sonography may be used as a simple, noninvasive
method in the diagnosis and functional evaluation
of patients with ADPKD. RI and morphologic
indices are useful parameters in the quantitative
evaluation of the severity of the disease and may
reflect renal functional status.
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